Blacksmith Medicines Co-Founder Presents at the 21st International Conference on Biological Inorganic Chemistry
Presentation highlights Blacksmith's novel chemistry platform for targeting metalloenzymes and FG-2101, a first-in-class non-hydroxamate LpxC inhibitor Professor of Chemistry and Biochemistry, U.C. Presentation highlights Blacksmith's novel chemistry platform for targeting metalloenzymes and FG-2101, a first-in-class non-hydroxamate LpxC inhibitor SAN DIEGO, Aug.